Business
CB Scientific (CBSC) Purchases Marutronics LLC, Inventor of Medical Cannabis Delivery Device -- CB Scientific to Manufacture Proprietary Thermo-Responsive Cannabinoid Delivery Device for Global Delivery
CB Scientific (CBSC) Purchases Marutronics LLC, Inventor of Medical Cannabis Delivery Device -- CB Scientific to Manufacture Proprietary Thermo-Responsive Cannabinoid Delivery Device for Global Delivery.
About this update from Cardiac Biotech Solutions Inc.
[{"type":"text","content":"\n \n \n CB Scientific (CBSC) Purchases Marutronics LLC, Inventor of Medical Cannabis Delivery Device -- CB Scientific to Manufacture Proprietary Thermo-Responsive Cannabinoid Delivery Device for Global Delivery\n \n \nCB Scientific (CBSC) Purchases Marutronics LLC, Inventor of Medical Cannabis Delivery Device -- CB Scientific to Manufacture Proprietary Thermo-Responsive Cannabinoid Delivery Device for Global Delivery\n \n DENVER, CO--(Marketwired - Mar 13, 2017) - CB Scientific, Inc. (OTC PINK: CBSC), a designer, developer and manufacturer of Cannabis Analytical Tools and Devices, Cannabis Medical Delivery Systems and Personal Analytical Kits and Devices, announces today that the Company, on February 24th, completed a Stock For Asset Exchange Agreement with Marutronics LLC, a Florida Limited Liability Company (MMD) and Bobban Subhadra and Vijitha Vivekanandan, equal members of MMD. Subject to the terms and conditions of the agreement, the MMD Members delivered all their Membership Interests and IP rights (patents, trademark, trade secrets) to CBSC and in return CBSC transfers to the MMD Members (a) seven million five-hundred thousand (7,500,000) newly issued restricted shares of Common Stock of CBSC and (b) five million (5,000,000) shares of Common Stock at par value as stock options.\n As part of the agreement, Mr. Bobban Subhadra has been elected as the Chief Operating Office of the Company and will also serve on the Board of Directors of CB Scientific.\n Marutronics LLC, has the following patent applications which will be transferred to the Company;\n 1) Utility Patent-1 Cannabinoid delivery devices\n  Summary: A proprietary thermo-responsive cannabinoid delivery device for controlled release of precise doses of cannabinoids\n 2) Utility Patent-2 Cannabinoid transdermal formulations\n  Novel epidermal penetrating compounds for enhanced and sustained neural delivery of cannabinoids\n 3) Utility Patent-3 Cannabinoid detection unit\n  Summary: A proprietary device to semi-quantitatively profile the amount of various cannabinoids in various samples. This combo unit is based on thin-layer chromatography for detecting cannabinoid compound.\n Dr. Subhadra conducted his doctoral studies in Microbiology and Immunology at School of Medicine, University of New Mexico. After graduating he researched on the role of neurose...